Skip to Main Content

Current Funding Opportunities

Click here to visit the NCI grant site.

Use your device's search function to find a specific disease or funding source. 


Funding

The Vera and Joseph Dresner Foundation  MDS Research Fund
The fund will facilitate the advancement of innovative basic science, translational or clinical research to advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders (such as MDS/myeloproliferative neoplasms (MPN) overlap syndromes, secondary acute myeloid leukemia following MDS, idiopathic cytopenia of undetermined significance (ICUS), or clonal hematopoiesis of indeterminate potential (CHIP). 

The foundation will consider proposals from individuals at university, college, hospital, or laboratory institutions for support of research in MDS or related disorders in two types:
- Early Career Awards 
- Established Investigator Awards

Letter of Intent (LOI) Deadline: LOIs are accepted on a rolling basis. 
Learn More>> 
Thank 

Department of Defense Lung Cancer Research Program

The FY20 Defense Appropriations Act provides funding to the Department of Defense Lung Cancer Research Program (LCRP) to support innovative, high-impact lung cancer research. Pre-application and application deadlines will be available when the Program Announcements are released.

Learn more about the DoD Lung Award>>

 

Cancer Research Institute Postdoctoral Fellowship

The CRI Irvington Postdoctoral Fellowship Program supports qualified young scientists at leading universities and research centers around the world who wish to receive training in fundamental immunology or cancer immunology.

Application Deadline: April 1, 2020

Learn more about the CRI fellowship>>


Alex’s Lemonade Stand Familial RUNX1 Grant Program

The RUNX1 Research Program is dedicated to advancing areas of research of particular importance to families affected by familial platelet disorders (FPDs) leading to acute myeloid leukemia (AML) due to germline RUNX1 mutations with the ultimate goal of developing effective therapies to prevent the onset of AML.

Application Deadline: April 1, 2020

https://www.alexslemonade.org/campaign/researchers-reviewers/runx1


Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21 and R01)

The purpose of the initiative is to support multidisciplinary exploratory or developmental research to understand the underlying etiologic factors and mechanisms that contribute to population-level disparities in chronic liver diseases and liver cancer in the U.S.

Application Deadlines: April 1, 2020

Learn more about the R21 Liver disease award>>

Learn more about the R01 Liver disease award>>


V Foundation Grants

The V Foundation funds research for many types of cancer. Their Scientific Advisory Committee selects grant recipients through a highly competitive process and invest in promising people and projects.

Application Deadline: April 2, 2020

Learn more about the V Foundation Grants>>


Pfizer Patient Education in Chronic Myeloid Leukemia (CML) Competitive Grant Program

Projects that will be considered for Pfizer support will focus on advancing patient education about CML and improving the patient’s ability to make informed decisions about their care.

Application Deadline: April 7, 2020

Learn more about the Pfizer CML Grant>>

 

Pfizer MAPK inhibition in Melanoma RFP

Projects that will be considered for Pfizer support will focus on increasing the understanding of MAPK pathway inhibitors and their use in the treatment of

melanoma.

Application Deadline: April 15, 2020

Learn more about the Pfizer MAPK RFP>>

 

HIV/AIDS and the Tumor Niche (U54)

The purpose of FOA is to advance our understanding of the role of the tumor niche or microenvironment in the risks, development, progression, and diagnosis of cancer observed in individuals with an underlying HIV infection or AIDS.

Application Deadline: April 15, 2020

Learn more about HIV/AIDS award>> 


Prostate Cancer Foundation Awards

The PCF is pleased to announce a Request for Team Science Applications for PCF Challenge Awards for investigations of metastatic, lethal prostate cancer. These awards will be funded depending on the level of innovation in applications received.

Application Deadline: April 17, 2020

Learn more about the PCF Awards>>


NCCN Taiho Futibatinib Request for Proposals

NCCN is pleased to announce that it is collaborating with Taiho Oncology, Inc., to offer a new opportunity for the design and performance of clinical and correlative studies of futibatinib, a fibroblast growth factor receptor antagonist, in the treatment of solid tumors.

Application Deadline: April 29, 2020

Learn more about the NCCN Taiho RFPs>>


Elsa U. Pardee Foundation Research Grants

The Elsa U. Pardee Foundation funds research to investigators in United States non-profit institutions proposing research directed toward identifying new treatments or cures for cancer.

Application Deadline: April 30, 2020

Learn more about the Elsa Pardee Grants>>


Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 and R21)

The purpose of this FOA is to support research projects designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions Initiative.

Application Deadline: April 30, 2020

Learn more about the NCI R01 Provocative Questions Award>>

Learn more about the NCI R21 Provocative Questions Award>>



DoD Peer Reviewed Cancer Research Program  Funding Opportunities 

The FY20 Defense Appropriations Act provides funding to the DoD Peer Reviewed Cancer Research Program (PRCRP) to support innovative, high-impact cancer research.

  • Virtual Cancer Center Director Award – Letter of Intent due July 30, 2020
  • Career Development Award – Fellow Option – Letter of Intent due July 30, 2020
  • Career Development Award – Cancer Center Scholar Option – Letter of Intent due July 30, 2020
  • Idea Award – Preproposal due May 14,  2020
  • Impact Award – Preproposal due May 14, 2020
  • Behavioral Health Science Award – Letter of Intent due July 30, 2020
  • Translational Team Science Award – Letter of Intent due July 30, 2020 

Learn more about the DoD PRCRP funding>>


Gordon and Betty Moore Foundation Development of Clinical Quality Measures to Improve Diagnosis RFP 

The purpose of this FO is to provide assistance in the form of grants for the development of innovative clinical quality measures that promote excellence in diagnosis of three categories of disease – acute vascular events, infections and cancer.

Application Deadline: May 4, 2020

Learn more about the Gordon and Betty Moore RFP>>


The Mark Foundation Emerging Leader Award

This Award provides grant support to early career investigators conducting high-impact, high-risk cancer research. This award is intended to support highly promising projects for which other sources of funding are not readily available or for a separate innovative endeavor that will allow the applicant to pursue a distinct and novel research direction.

Letter of Intent Due: May 10, 2020

Learn more about the Mark Foundation Award>>


Ovarian Cancer Research Fund Alliance Collaborative Research Development Grant

This Grant provides funds for large ovarian cancer research projects that involve several investigators within one institution or collaborations between groups in multiple institutions.

Letter of Intent Due: May 15, 2020

Learn more about the Ovarian Cancer Alliance Grant>>


Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01)

This FOA is to enable the translation of nanotechnology-based cancer interventions relying on next-generation nanoparticle formulations and/or nano-devices.

Application Deadline: May 21, 2020

Learn more about the TTNCI RO1>>


Genomic Expert Curation Panels (U24)

The purpose of this FOA is to establish expert panels that will select genes and genomic variants associated with diseases or conditions of high priority to participating NIH Institutes and Centers (ICs) and systematically determine their clinical significance for diagnosis and treatment of these diseases or conditions.

Application Deadline: May 27, 2020

Learn more about genomic panels U24>>


2020 Associazione Mia Neri Foundation Onlus Pediatric Oncology Grants

The Associazione Mia Neri Foundation Onlus will fund a basic research project in the field of pediatric brain tumors with a 100,000 € grant over a two-year period.

Application Deadline: May 31, 2020

Learn more about the 2020 Mia Neri Grants>>


When Everyone Survives Foundation RFP

This RFP is offered by the When Everyone Survives Foundation (WES Leukemia Research Foundation) to solicit innovative research in leukemia.

Application Deadline: June 1, 2020

Learn more about the WES RFP>>



Prostate Cancer Research Program (PCRP)

The PCRP seeks to promote highly innovative, groundbreaking research; high-impact research with near-term clinical relevance; the next generation of prostate cancer investigators through mentored research; and resources that will facilitate translational research.

Early Investigator Research Award - Letter of Intent due June 4, 2020

Physician Research Award - Letter of Intent due June 4, 2020

https://cdmrp.army.mil/funding/pcrp

Alex's Lemonade Stand Foundation Psychosocial Family Impact Grants

These Grants focus on psychosocial and behavioral health outcomes for children diagnosed with cancer and their families.

Letter of Intent Due: June 15, 2020

Learn more about the Alex's Lemonade Impact Grants>>


Alex's Lemonade Stand Foundation Psychosocial Launch Grants

These Grants focus on psychosocial and behavioral health outcomes for children diagnosed with cancer and their families.

Letter of Intent Due: June 15, 2020

Learn more about the Alex's Lemonade Psychosocial Grants>>



Surgical Disparities Research (R01)

The purpose of this (FOA) is to support investigative and collaborative research focused on understanding and addressing disparities in surgical care and outcomes, in minority and health disparity populations. 

Application Deadlines: June 5, 2020; June 5, 2021, June 5, 2022. Resubmission/revision applications: July 5, 2020, July 5, 2021, July 5, 2022



Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21)

The purpose of this FOA is to invite exploratory/developmental research grant applications (R21) for the development of innovative methods and algorithms in biomedical computing, informatics, and data science addressing priority needs across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. 

Application Deadline: June 9, 2020



Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01)

The purpose of this FOA is to invite Cooperative Agreement (U01) applications for the development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. 

Application Deadline: June 9, 2020



Advanced Development of Informatics Technologies for Cancer Research and Management (U24) 

The purpose of this FOA is to invite Cooperative Agreement (U24) applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. 

Application Deadline: June 9, 2020



Sustained Support for Informatics Technologies for Cancer Research and Management (U24) 

The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for the continued development and sustainment of high value informatics research resources to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. 

Application Deadline: June 9, 2020



Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and AYA Cancer Survivors (R01 and R21)

Through this FOA the NCI invites applications describing research focused on improving care and health-related quality of life for childhood, and adolescent and young adult cancer survivors.

Application Deadline: July 31, 2020